AU2002216863B8 - Streptococcus pyogenes antigens and corresponding DNA fragments - Google Patents

Streptococcus pyogenes antigens and corresponding DNA fragments Download PDF

Info

Publication number
AU2002216863B8
AU2002216863B8 AU2002216863A AU2002216863A AU2002216863B8 AU 2002216863 B8 AU2002216863 B8 AU 2002216863B8 AU 2002216863 A AU2002216863 A AU 2002216863A AU 2002216863 A AU2002216863 A AU 2002216863A AU 2002216863 B8 AU2002216863 B8 AU 2002216863B8
Authority
AU
Australia
Prior art keywords
polypeptide
amino acid
seq
acid sequence
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002216863A
Other languages
English (en)
Other versions
AU2002216863B2 (en
AU2002216863A1 (en
Inventor
Bernard R. Brodeur
Josee Hamel
Denis Martin
Patrick Rheault
Stephane Rioux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Quebec
Original Assignee
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Biomedical Corp of Quebec filed Critical ID Biomedical Corp of Quebec
Publication of AU2002216863A1 publication Critical patent/AU2002216863A1/en
Assigned to ID BIOMEDICAL CORPORATION reassignment ID BIOMEDICAL CORPORATION Request for Assignment Assignors: SHIRE BIOCHEM, INC.
Application granted granted Critical
Publication of AU2002216863B2 publication Critical patent/AU2002216863B2/en
Publication of AU2002216863B8 publication Critical patent/AU2002216863B8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
AU2002216863A 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding DNA fragments Ceased AU2002216863B8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21
US60/256,940 2000-12-21
PCT/CA2001/001853 WO2002050107A2 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Publications (3)

Publication Number Publication Date
AU2002216863A1 AU2002216863A1 (en) 2002-09-05
AU2002216863B2 AU2002216863B2 (en) 2008-02-28
AU2002216863B8 true AU2002216863B8 (en) 2008-03-20

Family

ID=22974225

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002216863A Ceased AU2002216863B8 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding DNA fragments
AU1686302A Pending AU1686302A (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU1686302A Pending AU1686302A (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Country Status (12)

Country Link
US (5) US7595057B2 (cg-RX-API-DMAC7.html)
EP (1) EP1343895B1 (cg-RX-API-DMAC7.html)
JP (1) JP4080876B2 (cg-RX-API-DMAC7.html)
AT (1) ATE398677T1 (cg-RX-API-DMAC7.html)
AU (2) AU2002216863B8 (cg-RX-API-DMAC7.html)
BE (1) BE2021C506I2 (cg-RX-API-DMAC7.html)
BR (1) BR0116704A (cg-RX-API-DMAC7.html)
CA (2) CA2789252C (cg-RX-API-DMAC7.html)
DE (1) DE60134494D1 (cg-RX-API-DMAC7.html)
ES (1) ES2307564T3 (cg-RX-API-DMAC7.html)
FR (1) FR21C1005I2 (cg-RX-API-DMAC7.html)
WO (1) WO2002050107A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
EP1660660B1 (en) * 2003-08-15 2013-07-24 ID Biomedical Corporation of Quebec Pharmaceutical compositions for use in the treatment of Streptococcus Pyogenes infection
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
AU2024241785A1 (en) * 2023-03-29 2025-11-13 Cyrus Biotechnology, Inc. Ides variant proteins and methods of using the same

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
ID27482A (id) * 1998-02-20 2001-04-12 Iaf Biochem Int Antigen streptococcus kelompok b
GB9807890D0 (en) 1998-04-09 1998-06-10 Actinova Ltd Peptides
WO2000006737A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
CA2337102A1 (en) 1998-07-27 2000-02-10 Richard William Falla Le Page Nucleic acids and proteins from group b streptococcus
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
JP4718099B2 (ja) * 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原
AU2002210301A1 (en) * 2000-10-13 2002-04-22 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
EP1328543B1 (en) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
WO2002066650A2 (en) * 2001-02-21 2002-08-29 Shire Biochem Inc. Streptococcus pyogenes polypeptides and corresponding dna fragments
EP1421098A4 (en) * 2001-04-13 2006-03-15 Wyeth Corp SURFACE PROTEINS OF STREPTOCOCCUS PYOGENES
DE60234772D1 (de) * 2001-07-06 2010-01-28 Id Biomedical Corp Gruppe-b streptococcus antigene und entsprechende dna-fragmente
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
AU2002351623A1 (en) * 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
WO2004007725A1 (en) * 2002-07-15 2004-01-22 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
EP1660660B1 (en) * 2003-08-15 2013-07-24 ID Biomedical Corporation of Quebec Pharmaceutical compositions for use in the treatment of Streptococcus Pyogenes infection
EP1807446A2 (en) * 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
ATE548049T1 (de) * 2005-06-09 2012-03-15 Hansa Medical Ab Verwendung von ides proteinase (von s. pyogenes) zur behandlung von autoimmunkrankheiten und transplantatabstossung
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
CN101889082A (zh) * 2007-09-14 2010-11-17 季诺维斯公司 用于解离Fcgamma-受体-IgG复合物以及纯化与检测IgG的方法和试剂盒
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Also Published As

Publication number Publication date
US20160326221A1 (en) 2016-11-10
US8298551B2 (en) 2012-10-30
ES2307564T9 (es) 2021-04-26
CA2432525C (en) 2012-11-27
CA2789252A1 (en) 2002-06-27
US20150017684A1 (en) 2015-01-15
BR0116704A (pt) 2003-12-23
US20040097706A1 (en) 2004-05-20
JP2004524014A (ja) 2004-08-12
AU2002216863B2 (en) 2008-02-28
EP1343895B1 (en) 2008-06-18
AU1686302A (en) 2002-07-01
US20130136760A1 (en) 2013-05-30
DE60134494D1 (de) 2008-07-31
WO2002050107A2 (en) 2002-06-27
ATE398677T1 (de) 2008-07-15
US8821895B2 (en) 2014-09-02
FR21C1005I1 (cg-RX-API-DMAC7.html) 2021-03-26
US9340586B2 (en) 2016-05-17
FR21C1005I2 (fr) 2022-01-14
CA2789252C (en) 2016-11-15
CA2432525A1 (en) 2002-06-27
JP4080876B2 (ja) 2008-04-23
ES2307564T3 (es) 2008-12-01
BE2021C506I2 (cg-RX-API-DMAC7.html) 2021-05-31
EP1343895A2 (en) 2003-09-17
US20100119507A1 (en) 2010-05-13
WO2002050107A3 (en) 2003-04-10
US7595057B2 (en) 2009-09-29

Similar Documents

Publication Publication Date Title
US20080038268A1 (en) Streptococcus Pyogenes Antigens
US7883706B2 (en) Methods for using Streptococcus pyogenes polypeptides
US20160326221A1 (en) Streptococcus pyogenes antigens and corresponding dna fragments
AU2002234455A1 (en) Streptococcus pyogenes polypeptides and corresponding DNA fragments
EP1660660B1 (en) Pharmaceutical compositions for use in the treatment of Streptococcus Pyogenes infection
AU2002317107A1 (en) Group B streptococcus antigens and corresponding DNA fragments
WO2004007725A1 (en) Polypeptide of streptococcus pyogenes
AU2001272270B2 (en) Streptococcus pyogenes antigen
WO2002079475A2 (en) Streptococcus pyogenes antigens and corresponding dna fragments
WO2002088178A2 (en) Antigens of group b streptococcus and corresponding dna fragments
AU2001272270A1 (en) Streptococcus pyogenes antigen

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ID BIOMEDICAL CORPORATION

Free format text: FORMER APPLICANT(S): SHIRE BIOCHEM, INC.

TH Corrigenda

Free format text: IN VOL 22, NO 9, PAGE(S) 1034 UNDER THE HEADING APPLICATIONS ACCEPTED -NAME INDEX UNDER THE NAME ID BIOMEDICAL CORPORATION, APPLICATION NO. 2002216863 , UNDER INID (72), CORRECT THE CO-INVENTOR NAME TO READ BRODEUR, BERNARD R.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired